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doi:10.1016/j.ejvs.2009.06.001Abstract Objective: To evaluate the causes and results of conversion to open repair after
aortic aneurysm endovascular treatment (EVAR).
Design: Retrospective study of open conversion after EVAR was performed in eight French
academic centres. Primary conversion (PC) within 30 days after EVAR and secondary conver-
sions (SC) were analysed separately.
Result: Between 1997 and 2007, open conversions were performed in 34 patients (most often
in high-risk patients): 14 PC and 20 SC. Two main causes of PC were unfavourable iliac artery
anatomy and renal artery coverage. In hospital mortality was 21%. SC occurred at a median of
44 months after primary EVAR. Nine were urgent cases for rupture or infection and 11 elective
for aneurysm growth, infection or thrombosis. Early mortality was similar after emergent or
elective SC (25%).
Conclusion: Open conversion, and, in particular, PC and urgent SC, was associated with a poor
outcome. According to the literature, mortality after elective SC is low but remains high in
high-risk patients.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.3rd Annual Congress of the
rasbourg, France, June 2008.
chirurgie vasculaire Pavillon
nval, 69437 LYON Cedex 03,
þ33 4 72 11 75 57.
mail.com (A. Millon).
lon, Pierre-Edouard Magnan,
lippe Patra.
ty for Vascular Surgery. PublisheSince the first successful endovascular treatment of an
abdominal aortic aneurysm (AAA) in 1991, this procedure is
performed with an increasing frequency.1 This minimally
invasive approach has lower early morbidity and mortality
rates compared to open surgery, especially in high-risk
patients.2e4 However, there are some early and delayed
failures leading to primary or secondary conversion to open
repair.5e7 Open repair is sometimes performed in and by Elsevier Ltd. All rights reserved.
Table 1 Causes of open conversion.
Causes n
Primary
conversion
(n Z 14)
Iliac calcification
and tortuosity
6
Renal artery occlusion 4
Technical problem
during graft deployment
2
Type 3 Endoleak 1
Immediate post
procedure graft thrombosis
1
Urgent secondary
conversion
(n Z 8)
Ruptured AAA 5
Fissured AAA 2
Endograft Infection 1
Elective secondary
conversion
(n Z 12)
AAA diameter
increase with endoleak
8
Distal type I endoleak 1
Endograft infection 1
Endograft thrombosis 1
Cross-over bypass infection 1
430 A. Millon et al.emergent manner (such as iliac rupture, stent-graft
misdeployment and aneurysm rupture) or in an elective
manner (primary or secondary endoleak with or without sac
expansion). In most cases, operative risk may be considered
higher than that of a primary open repair due to intra-aortic
stent graft and emergent conditions.8
The aim of this study was to report outcomes of
conversion to open repair during primary endovascular
treatment or during follow-up in eight French academic
centres. Until very recently, EVAR was still considered
under evaluation, and follow-up was compulsory according
to the AFSSAPS guidelines.9
Material and methods
Between September 1997 and September 2007, a total of
1588 patients were treated by endograft for AAA in eight
French vascular surgery departments (University Hospital of
Bordeaux, Grenoble, Lille, Lyon, Marseille, Nantes, Nice and
Saint-Etienne). All patients who underwent open conversion
peroperatively or during follow-up were included in this
study. Data retrieved for these cases were collected retro-
spectively; however, data for the remaining patients who did
not undergo open conversion were not collected.
Primary conversion (PC) has been defined by an AAA
open repair with aortic cross clamping within 30 days
following the primary EVAR. Secondary conversion (SC) has
been defined by an AAA open repair performed at least 30
days after stent-graft placement. These SCs were either
performed in an elective or urgent condition.
Data reviewed included demographic information, initial
aortic aneurysm morphology at the time of EVAR, time to
conversion and indications for conversion. The intra-oper-
ative variables (e.g., approach, clamp location, endograft
explantation, blood transfusion, clamping and operative
time) were also examined. The postoperative course data
included major perioperative (<30 days) complications
(such as myocardial infarction, renal failure, respiratory
failure or pneumopathy, complications requiring re-opera-
tion and death), length of intensive care unit stay and
hospital length of stay was obtained from the medical
record.
Results are expressed as mean  standard deviation (SD)
(range) for continuous data and as percentage for cate-
gorical data.
Results
A total of 34 patients (2.1% of all cases treated by EVAR)
required open conversion. Fourteen were PC and 20 were
SC (0.9% and 1.3%, respectively, of all cases treated by
EVAR). The study cohort included 33 male and one female
patient, with a mean age of 73 years (range: 57e84 years).
The cardiovascular co-morbidities were similar to those in
patient suffering from AAA reported elsewhere. Twenty-
nine patients suffered from at least one co-morbidity,
according to the AFSSAPS (Agence Franc¸aise de Se´curite´
Sanitaire des Produits de Sante´) criteria,9 and could thus
be considered high-surgical-risk patients. Aneurysm
morphology before stent-graft placement of these patients
was analysed. Mean aneurysm diameter was 59.1 mm(range: 45e110 mm) and was comparable between both the
groups. Only one patient who presented a rapidly growing
aneurysm had an aneurysm diameter lesser than 50 mm.
Causes of PC
Thirteen PCs were performed peroperatively and one on
the day following EVAR. The devices used were Talent
(Medtronic, USA) in eight cases, Zenith (Cook, USA) in four
and Vanguard (Boston Scientific, USA) in one (Table 1).
Five causes of early failure could be described. Most
frequently (six of 14), failure was due to impossiblity of
endograft progression because of the morphology of the
external iliac artery (calcification and tortuosity), leading
to an iliac rupture in three cases. Devices concerned were
four Talent and one each of Zenith and Vanguard. The
second most frequent cause of PC was an inappropriate
stent-graft placement over renal artery in four cases (two
each of Talent and Zenith). The remaining four causes of
PC are detailed below. In one case, the angiographic
catheter was locked in a suprarenal hook of a Zenith
endograft. Attempts to retrieve the catheter led to
misplacement of the suprarenal bare stent. In the second
case, impossibility to deliver the whole of a Zenith
endograft from its delivery shaft led to open conversion. In
the third case, conversion was due to type 3 endoleak and
the absence of additional endovascular material for addi-
tional treatment (Talent). In the last case, conversion was
performed after failure of endovascular treatment of
a stent-graft thrombosis (Talent) 2 h after successful
deployment without difficulty. At open surgery, no cause
could be defined.
Causes of SC
Twenty SCs were performed. Of these, eight were per-
formed in urgent conditions and 12 electively. Mean
interval between primary endovascular procedure and open
Table 2 Surgical details of primary and secondary
conversions.
All
Conversions
(n Z 34)
Primary
Conversions
(n Z 14)
Secondary
Conversions
(n Z 20)
Approach
Transperitoneal 30 13 17
Retroperitoneal 4 1 3
Clamp location
Supraceliac 2 0 2
Suprarenal 11 5 6
Interrenal 2 0 2
Infrarenal 17 7 10
Aortic ballon
occlusion
2 2 0
Endograft Explantation
Partial 3 0 3
Complete 31 14 17
Mean Aortic
Clamping Time (min)
Suprarenal 35.5 28.4 39.4
Total 63.7 57.3 68.3
Blood Transfusion
Patients (n) 27 11 16
Mean Units 7 7 7
Mean Operative
Time (min)
247 265 233
Open conversion after EVAR 431conversion was 41 months (range: 2e117 months). Mean sac
enlargement between EVAR and SC was 11 mm (range: 8
to þ40 mm). The related endograft were Talent in eight
cases, Vanguard in five, Power link in three, AneurX in
two and custom-made endograft in two cases. Endogaft
were bifurcated in 15 cases and aorto-mono-iliac in five
cases. Seven of the 20 patients had required secondary
endovascular procedures before open conversion and two
were lost to follow-up.
Eight SCs were performed in urgent condition for six
cases of aneurysm rupture and for two cases of symptom-
atic aneurysm. Rupture was due to known aneurysm growth
in four cases out of six.
Rupture was unexpected in the last two cases. One
patient was successfully treated 5 years before sac
regression presented a type III aortic dissection leading to
rupture. We could not define either the mechanism of this
dissection, or the relation between aortic dissection and
the aortic endograft. The last patient had been successfully
treated with a custom-made endograft. He presented 117
months later with a septic rupture of the anterior wall of
the aneurysm caused by Salmonella infection.
Two patients were admitted in the emergency room
for an acute abdominal pain. One was lost to follow-up,
in whom computed tompgraphy (CT) scan revealed a sac
enlargement without any sign of rupture. An endograft
migration with a proximal aortic neck dilatation (diam-
eter >34 mm) was diagnosed. The second patient had
two successful re-interventions for distal type I endo-
leak (external iliac extension and contralateral iliac
ligation for occluder endoleak). He then developed
a proximal type I endoleak secondary to aortic neck
dilatation. At that time, the patient refused conversion
to open repair.
Twelve elective conversions to open repair were per-
formed. Indication was aneurysm diameter increase in
eight cases. This increase was related to a proximal type I
endoleak in five cases (three aortic neck dilatation and two
endograft migration), type III endoleak in two cases and
distal type I endoleak in one case (endograft migration in an
iliac aneurysm). Endovascular re-intervention was per-
formed before conversion in two out of these eight
patients.
One elective conversion to open repair was performed
for a distal type I endoleak without aortic sac enlargement.
This patient preferred open conversion.
The last three elective conversions were indicated for
sepsis: iliac leg thrombosis with fever 45 days after Talent
endograft deployment; endograft infection secondary to
recurrent groin infection; and femoro-femoral cross-over
bypass graft infection.Surgical details
Surgical details (approach, clamp location, endograft
explantation, blood transfusion, clamping and operative
time) are outlined in Table 2.
Aortic cross clamping was performed with a usual clamp,
except in two cases of PC, using an aortic balloon occlusion.
Endograft explantation was complete in all the cases of PC
and in 17 cases of SC. Preservation of part of the endograftwas performed in three cases. One suprarenal stent of
a Talent endograft and two iliac legs of two Vanguard
endografts were left in situ.
Aortic reconstruction was tube graft in three cases,
aorto-bi-iliac bypass in four and aorto-bifemoral bypass in
seven cases in the PC group. In the SC group, four aorto-
aortic, nine aorto-bi-iliac and four aorto-bifemoral
bypasses were performed. No aorto-duodenal fistula was
found in the cases of endograft infection. Aortic rupture by
Salmonella was treated by an in situ reconstruction with
a Dacron Silver graft. For the three other cases of infec-
tion, two standard Dacron graft and one cryopreserved
arterial allograft were used.
In the PC group, renal re-vascularisation was performed
in three cases of renal artery coverage by the endograft
(aorto-renal bypass, renal artery thrombectomy, renal
artery re-implantation). In the SC group, one renal artery
injury during aortic cross clamping required aorto-renal
bypass.
Results of primary conversion
All patients were transferred to an intensive care unit for
a mean stay of 5.7 days (range: 2e24 days). Three patients
(21%) died within 30 days following the open conversion.
One died on the third postoperative day of multi-organ
failure secondary to haemorrhagic shock related to an iliac
rupture. An 81-year-old patient with a medical history of
Table 3 Primary conversion rate and in hospital mortality.
Authors Year Patients Primary
Conversion
(%)
Mortality
at Day 30
(%)
Dattilo7 2002 362 5 (1.4) 1 (25)
Lyden15 2002 110 3 (2.7) 0
Chaikov16 2002 236 9 (3.8) 0
Verhoeven14 2004 308 1 (0.3) 0
Verzini17 2006 649 9 (1.4) 2 (22)
Tiesenhausen18 2006 117 7 (5.9) 2 (28.5)
Jimenez19 2007 574 5 (0.9) 2 (12)
EUROSTAR5 2004 4613 45 (1.0) 6 (13)
Lifeline Registry10 2005 2664 68 (2.5) 5 (7.4)
AURC 2008 1588 14 (0.9) 3 (21)
Total 11 221 166 (1.5) 21 (1.3)
432 A. Millon et al.ischaemic cardiopathy died on the fourth postoperative day
of a massive myocardial infarction. The last death occurred
on the 15th postoperative day due to an acute respiratory
distress syndrome.
Five patients (36%) presented at least one major compli-
cation. There were three major medical complications: two
acute renal failures, which did not require dialysis, and one
pneumopathy. Four patients required re-operation (two for
haematomas and one each for wound abscess and acute
intestinal occlusion).
The mean hospital stay was 15.8 days (range: 8e34
days), and the mean follow-up duration after PC was 43.6
months (range: 3e128 days). One patient died at the third
month of myocardial infarction. The rest of the patients
were alive at 1 January 2008.
Results of secondary conversion
The mean stay in intensive care unit was 6.1 days (range:
1e38 days). Three patients (15%) died within the first 30
days. Two died after an emergent conversion and one
after an elective conversion. One patient, who suffered
from a ruptured 90-mm AAA with an unstable haemody-
namic condition at admission, died during the procedure.
An aorto-aortic bypass was performed by a trans-
peritoneal approach. He presented a ventricular fibrilla-
tion with collapse after aortic clamp removal. The second
death occurred after aorto-aortic bypass for a ruptured
AAA. Massive blood loss led to disseminated intravascular
coagulopathy and multi-organ failure (14th day). The
third death occurred in an 84-year-old man who suffered
from an AAA growth with a proximal type 1 endoleak
secondary to graft migration. Proximal aortic neck was
unsuitable for an endovascular approach. After an elec-
tive conversion to open repair, he presented an acute
renal failure requiring dialysis, and respiratory failure led
to his death (5th day).
Two other deaths occurred after the 30th day and were
related to the open conversion: a septic shock after ascites
infection in patient with cirrhosis (78th day) and an unex-
plained haemorrhagic shock (60th day) (no autopsy was
performed). The 30-day mortality after secondary conver-
sion was 25% (5 of 20). The mortality was the same after
emergent (2 of 8) or elective (3 of 12) conversion. Major
non-lethal morbidity rate was 50%, with six cases of renal
failure (two cases leading to dialysis), one myocardial
infarction and one acute limb ischaemia requiring re-
intervention.
The mean follow-up after SC was 37.4 months (range: 5e
72 months). Three patients died of AAA-unrelated causes
(one case each from pulmonary cancer at 56 months, respi-
ratory insufficiency at 46 months and oesophageal cancer at
6months). One late complication occurred during follow-up:
graft infection at 5 years leading to graft removal and in situ
reconstruction with a cryopreserved allograft.
Discussion
Our study shows the low incidence and the poor outcome of
conversion to open repair after endovascular abdominal
aneurysm repair.The rate of open conversion is hard to estimate but is
low compared to the high incidence of secondary inter-
vention after EVAR. The rate of secondary intervention
reported in the literature varies with a range from 8% to
27% depending on the length of follow-up.10e14 According to
the American Lifeline Registry, 22% patients needed
a secondary procedure at 5 years.10 European and American
registries estimate the rate of open conversion at 1.5% and
3.6% respectively.5,10 Our results confirm this trend.
However, interpretation is limited by the retrospective
nature of this study.
PC rate is between 0.8% and 6% according to the recent
studies (Table 3).5,7,10,14e19 This rate decreases as new
devices are available. Other factors could explain this
finding: surgical team experience, better understanding of
materials, better patient selection and better ability to
manage complications with an endovascular approach.
Causes of PC described by May et al. in 1998 have not
changed.20 Most often, PCs are due to device dysfunction
(stent-graft misdeployment, impossibility of shaft delivery
system removal, difficulty of the contralateral limb cathe-
terisation) or due to unfavourable iliac artery anatomy
(tortuous, calcified and low-inner-diameter iliac access
leading to an impossibility of device progression, iliac
dissection or rupture). In all cases of impossibility of stent-
graft progression or iliac rupture in our study, external iliac
artery inner diameter was superior to 7 mm. Iliac artery
extensive calcification and tortuosity were observed in all
these cases. The difficulties encountered were peroper-
ative findings. In our experience, suitability of iliac artery
access on the angio-CT is a real challenge in some cases.
The third most frequent cause is artery renal occlusion
secondary to coverage by endograft main body or proximal
extension. Two factors are associated with material (inac-
curate stent-graft deployment) and aortic neck
morphology. In our study, in three cases of renal artery
occlusion, the proximal aortic neck angulation was superior
to 60 and in one case proximal aortic neck angulation was
45 with a length of 10 mm. In these cases, preoperative
angio-CT should have led to discontinuation of endovascular
treatment. According to the American Lifeline Registry,
female gender is the only predictive factor of PC.10 In the
literature, mortality rate varies between 0% and 28.5%
Open conversion after EVAR 433(Table 3). This high rate is easily explained by the emergent
condition, the operative time and the frequent need of
a suprarenal aortic cross clamping. In our study, with most
patients considered at high operative risk, 30-day morbidity
and mortality rates were 36% and 21%, respectively. PC can
be divided in two groups: emergent (iliac rupture, graft
thrombosis, renal occlusion, etc.) and delayed (impossi-
bility of device progression). In our study, there were no
mortality cases where PC could be delayed.
SC rate is difficult to estimate and strongly depends on
follow-up (Table 4).5,10,14,17e19,21e25 The American and
European registries report a rate of 0.7% and 1.1%,
respectively.5,10 In two studies with a follow-up period
exceeding 36 months, this rate is estimated to be between
3.2% and 4.5%.14,17 This incidence seems unchanged even in
the recent studies as compared to PC. SCs are performed in
emergent condition for aneurysm rupture in patients lost to
follow-up or having refused elective open conversion. In our
study, eight SCs were performed in an emergent condition.
Two patients were lost to follow-up and four had refused an
elective SC. In one case, elective SC was not indicated by
the surgical team. The last patient, although closely fol-
lowed up, presented an unpredictable aortic rupture
following acute aortic dissection.
SC was also performed in elective conditions and for
aneurysm expansion in most cases (with or without endo-
leak diagnosed, with or without migration or disconnec-
tion). The other causes of elective SC are continuing
endoleak, stent-graft thrombosis or infection. No predic-
tive factor of SC has been identified.10 The technical
approach depends on the cause and the device design
(suprarenal stent, hooks or barbs). Retroperitoneal
approach can be employed to control the suprarenal aorta
and to remove a suprarenal stent.15,18 Stent-graft removal
can be partial. Suprarenal stent or iliac extension can be
left in situ to avoid extensive dissection, suprarenal aorta
cross clamping and dangerous traction on the aortic
wall.18,19,21 According to Lipsitz et al. partial or complete
endograft preservation simplifies the operative approach
and improves the outcome.21 Aortic cross clamping with
a balloon avoiding a suprarenal aortic dissection can alsoTable 4 Secondary conversion rate and in hospital mortality.
Authors Year Patients MeanTime since
EVAR month
Second
Electiv
Lipsitz21 2003 386 30 (10e64) 4
Terramani22 2003 319 24 (13) 7
Verhoeven14 2004 308 41 (24e64) 8
Kong23 2005 594 34 (17) 15
Verzini17 2006 649 33 (7e85) 25
Breewster24 2006 873 31 (6e96) 15
Tiesenhausen18 2006 117 42 (0.03e80.4) 20
Jimenez19 2007 574 26.5 (25) e
Kelso25 2009 1606 33.3 (3e93) e
EUROSTAR5 2004 3595 32 (3e60) 20
Lifeline Registry10 2005 2664 e e
AURC 2008 1588 41 (2e117) 12
Total 13 273ease the technique. This approach has been rarely
described. No case has been reported in our study. Results
of SC have to be analysed separately for urgent or elective
cases. Only few cases of urgent SC have been reported in
the literature. Thus, it is difficult to precisely estimate
mortality rates (Table 4). Kelso et al. have recently repor-
ted a 30-day mortality rate of 50% after urgent SC (10
cases).25 Some authors suggest that the presence of an
aortic endograft constitutes a protection in case of AAA
rupture in terms of improved haemodynamic stability and
therefore mortality.17 This hypothesis has not yet been
demonstrated. Coppi et al. in a recent study outlined this
trend without statistical significance.26 The 30-day
mortality after urgent SC in our study (25%) confirms this
trend. Close follow-up is now widely recommended, espe-
cially for the first-generation devices.11,27 This approach
should decrease the need for emergent conversion to open
repair.
Furthermore, the two postoperative deaths occurred in
ASA 3-classified octogenarians.
In contrast, published studies of elective SC report
a very low mortality rate (Table 4). In our experience
(12 cases), only one death occurred within the 30 post-
operative days (8.3%). Two other patients died weeks later
(60th and 78th postoperative day), of complications related
to the SC. Early mortality rate thus increases to 25%. This
could be easily explained by the high-risk status of the
patients (two were octogenarians and one suffered from
alcoholic cirrhosis). In the five patients without high-
surgical-risk criteria (one emergent case for rupture and
four elective), no death occurred.
Conversion to open repair after EVAR represents a low
part of secondary re-intervention. However, with the
growing number of patients treated by EVAR with an
important follow-up, management of EVAR failure is
becoming a current and challenging issue. PC and SC per-
formed in urgent condition have high perioperative
morbidity and mortality, whatever the operative risk
status. These results can be improved by better patient
selection, development of more appropriate materials and
attentive follow-up. Elective secondary open conversionary conversions n (%) Mortality at day 30 n (%)
e Urgent Total Elective Urgent Total
7 11 (0.4) 1 (25) 1 (14) 2 (18)
2 9 (2.8) e e 1 (11)
1 9 (3.2) 0 0 0
1 16 (2.7) 0 1 (100) 1 (6.5)
4 29 (4.5) 0 0 0
5 20 (1.7) 2 (13) 2 (40) 4 (20)
6 26 (22) 0 3 (50) 3 (14)
e 12 (2.1) 0 0 0
e 25 (1.6) 2 (6.4) 5 (50) 7 (17)
6 26 (0.7) e e e
e 28 (1.1) 0 0 0
8 20 (1.2) 1 (8.3) 2 (25) 3 (15)
231 (1.7) 21 (10.2)
434 A. Millon et al.must be considered as a therapeutic option especially in
patients fit for open surgery with an acceptable mortality
and morbidity rate. In high-risk patients, this rate remains
high. In these patients, anatomic suitability criteria should
be strictly followed as well as close follow-up should be
maintained.
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